Medical Condition News

RSS

Implantation of sleep apnea device can lead to improvements for patients with OSA

Implantation of a sleep apnea device called Inspire- Upper Airway Stimulation therapy can lead to significant improvements for patients with obstructive sleep apnea, according to a study published today in the New England Journal of Medicine.

9 Jan 2014

Poor people more likely to become frail after a heart attack

As people get older, their bodies wear down and become less resilient. In old age, it's common for people to become "clinically frail," and this "frailty syndrome" is emerging in the field of public health as a powerful predictor of healthcare use and death.

9 Jan 2014

Study explores relationship between avocado consumption, satiety and blood sugar

New research published in the November issue of Nutrition Journal reports adding one-half of a fresh avocado to a lunch may have helped healthy, overweight people feel more satisfied and reduced their desire to eat following a meal. The study was funded by the Hass Avocado Board.

9 Jan 2014

Proteon's PRT-201 gets orphan drug designation for prevention of arteriovenous access dysfunction

Proteon Therapeutics, Inc., a privately held biopharmaceutical company developing novel, first-in-class pharmaceuticals to address the critical medical needs of patients with kidney and vascular diseases, today announced that its lead product, PRT-201, has received orphan drug designation in the European Union for the prevention of arteriovenous access dysfunction in hemodialysis patients.

9 Jan 2014

Older firefighters exposed to heat stress on job could be more resilient over time

Older firefighters who are chronically exposed to heat stress on the job could be more heat resilient over time. A recent study published in the December issue of the Journal of Occupational and Environmental Hygiene (JOEH) found that older firefighters may be able to tolerate more challenging or arduous work environments before they feel affected by the heat, compared to non-heat-exposed workers who would need to stop work prematurely.

9 Jan 2014

Research: New target for treating Huntington's and Parkinson's disease

Research from Western University (London, Canada) has revealed a possible new target for treating movement disorders such as Huntington's disease (HD) and Parkinson's disease. Stephen Ferguson, PhD, a scientist at Western's Robarts Research Institute, and Fabiola Ribeiro, PhD, of the Universidade Federal de Minas Gerais in Brazil found a definite improvement in motor behaviors in a HD mouse model when one of the major neurotransmitters in the brain, called Metabotropic Glutamate Receptor 5 (mGluR5) was deleted.

9 Jan 2014

Rexahn Pharmaceuticals initiates RX-3117 Phase Ib trial in cancer patients with solid tumors

Rexahn Pharmaceuticals, Inc. a clinical stage biopharmaceutical company, announced today the initiation of a Phase Ib clinical trial to study the safety and efficacy of RX-3117 in cancer patients with solid tumors.

9 Jan 2014

MicroRNA biomarker shows promise in predicting treatment response of ovarian cancer

Researchers at Case Western Reserve University have identified a microRNA biomarker that shows promise in predicting treatment response in the most common form of ovarian cancer - a breakthrough that has the potential to improve outcomes for patients with the disease.

9 Jan 2014

FDA approves Actavis' ANDA for Telmisartan Immediate-Release Tablets

Actavis plc today announced that it has received approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Telmisartan Immediate-Release Tablets, 20 mg, 40 mg and 80 mg, a generic equivalent to Boehringer Ingelheim's Micardis. Actavis intends to launch the product immediately.

9 Jan 2014

Study shows that anticoagulant medicine appears to protect patients against stroke

Heart palpitations. Shortness of breath. Tiredness. More and more people can recognise the symptoms of atrial fibrillation, which is one of the most common types of heart disease.

9 Jan 2014

Responsibility increases for parents who give electronic devices as Christmas gift to kids

Smartphones, laptops, tablets and video games were happily crossed off many the wish lists of many young children and teens this Christmas. But for parents, giving children electronic devices has to be about more than just saving Christmas, it has to be about making sure kids are safe when they start getting online.

9 Jan 2014

Researchers develop new, safer and noninvasive diagnostic technique for ulcers

Doctors may soon be able to diagnose stomach ulcers without taking tissue samples from the stomach. Researchers from the University of Southern Denmark now report to have developed a new, safer and noninvasive diagnostic technique for ulcers.

8 Jan 2014

Hebrew University research could lead to efficient and fast-acting antidepressant drugs

The World health Organization calls depression "the leading cause of disability worldwide," causing more years of disability than cancer, HIV/AIDS, and cardiovascular and respiratory diseases combined.

8 Jan 2014

Nociceptin in brain naturally moderates effects of stress

Collaborating scientists at The Scripps Research Institute (TSRI), the National Institutes of Health (NIH) and the University of Camerino in Italy have published new findings on a system in the brain that naturally moderates the effects of stress.

8 Jan 2014

Plasma thermogram can serve as an indicator of cervical cancer

Researchers at the University of Louisville have confirmed that using the heat profile from a person's blood, called a plasma thermogram, can serve as an indicator for the presence or absence of cervical cancer, including the stage of cancer.

8 Jan 2014

Working out while sick can actually do more harm than good, says professor

With the flu and cold season in full swing, kinesiology professor Karin Richards, at University of the Sciences in Philadelphia, said many people tend to ignore their symptoms to keep on track with their fitness resolutions for the New Year.

8 Jan 2014

Kalila Medical receives CE mark approval for Vado Steerable Introducer Sheath

Kalila Medical, a privately held medical device company focused on the development of next-generation steerable catheter technologies, today announced it has received CE mark approval for its Vado Steerable Introducer Sheath for vascular and intracardiac access including Atrial Fibrillation procedures.

8 Jan 2014

Immunocore, MedImmune sign oncology research collaboration and licensing agreement

Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, today announced that it has entered into an oncology research collaboration and licensing agreement with MedImmune, the global biologics research and development arm of AstraZeneca. Both companies will research and develop novel cancer therapies using Immunocore’s Immune Mobilising Monoclonal T-Cell Receptor Against Cancer technology.

8 Jan 2014

Emmaus completes all patient visits for Phase 3 trial of L-glutamine for treatment of sickle cell disease

Emmaus Medical, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of innovative and cost-effective treatments and therapies primarily for rare and orphan diseases, today announced it has completed all patient visits for its Phase 3 clinical trial for the treatment of sickle cell disease. Emmaus expects top-line data from the Phase 3 clinical trial to be available in the first quarter of 2014.

8 Jan 2014

No added benefit from aflibercept, shows study

For the third time in one year, the German Institute for Quality and Efficiency in Health Care (IQWiG) dealt with the drug aflibercept. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the Institute now examined whether aflibercept (trade name: Eylea) offers an added benefit over the appropriate comparator therapy in visual impairment due to macular oedema following occlusion of the central retinal vein.

8 Jan 2014

Medical Condition News

Implantation of sleep apnea device can lead to improvements for patients with OSA

Poor people more likely to become frail after a heart attack

Study explores relationship between avocado consumption, satiety and blood sugar

Proteon's PRT-201 gets orphan drug designation for prevention of arteriovenous access dysfunction

Older firefighters exposed to heat stress on job could be more resilient over time

Research: New target for treating Huntington's and Parkinson's disease

Rexahn Pharmaceuticals initiates RX-3117 Phase Ib trial in cancer patients with solid tumors

MicroRNA biomarker shows promise in predicting treatment response of ovarian cancer

FDA approves Actavis' ANDA for Telmisartan Immediate-Release Tablets

Study shows that anticoagulant medicine appears to protect patients against stroke

Responsibility increases for parents who give electronic devices as Christmas gift to kids

Researchers develop new, safer and noninvasive diagnostic technique for ulcers

Hebrew University research could lead to efficient and fast-acting antidepressant drugs

Nociceptin in brain naturally moderates effects of stress

Plasma thermogram can serve as an indicator of cervical cancer

Working out while sick can actually do more harm than good, says professor

Kalila Medical receives CE mark approval for Vado Steerable Introducer Sheath

Immunocore, MedImmune sign oncology research collaboration and licensing agreement

Emmaus completes all patient visits for Phase 3 trial of L-glutamine for treatment of sickle cell disease

No added benefit from aflibercept, shows study

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News